KMTSKestra Medical Technologies, Ltd.

$26.52

$14.5252 weeks$28.32

Price

$26.52+80%1Y

1M+23%1Y+80%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Below average

4/10

Value20

Quality36

Momentum59

Growth86

Strongest Growth, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. We have developed and are commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (“SCA”) during vulnerable periods of recovery.

In the company’s own words · 10-K filed Jul 14, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$1.16B

1Y Return+80%

5Y Return-

Kestra Medical Technologies, Ltd. (KMTS) reported revenue of $29M in Q4 2026 (quarter ended April 30, 2026), up 66% from the same quarter a year earlier. That came with a gross margin of 55% and net loss of $39M. For the full year FY2026, revenue was $95M (+59% year on year) and net income −$132M.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Medical Instruments & Supplies

Ranks #26 of 27 by Smart Score

Compare peers

BLFS+7.5%

BioLife Solutions, Inc.

STAAR Surgical Company

PLSE+7.4%

Pulse Biosciences, Inc.

LMAT+1.8%

LeMaitre Vascular, Inc.